Finding better targets for the treatment of atherothrombosis
By: Linda Haglund
Supervisor: Dr Magnus Grenegård
In the current search to find new, better, targets for the future management of thrombosis, emphasis should be put on two platelet thrombin receptors: protease activated receptor (PAR)1 and PAR4. It is important to clarify differences between these receptors in order to enhance their potential future as therapeutic targets.
Unactivated/Activated platelets
Responsible for this page:
Director of undergraduate studies Biology
Last updated:
05/06/09